| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
26,020,000 |
| Market
Cap: |
178.24(M) |
| Last
Volume: |
6,675 |
Avg
Vol: |
6,657 |
| 52
Week Range: |
$6.48 - $11.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Home Health Care |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fennec Pharmaceuticals is a biopharmaceutical company focused on the development of PEDMARK™ (sodium thiosulfate anhydrous injection) for the prevention of platinum-induced ototoxicity in pediatric cancer patients. Co. has licensed from Oregon Health & Science University intellectual property rights for the use of PEDMARK™ as a chemoprotectant and is developing PEDMARK™ as a protectant against the hearing loss caused by platinum-based anti-cancer agents in children.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
41,667 |
41,667 |
41,667 |
41,667 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
387,114 |
422,160 |
482,149 |
534,980 |
| Total Sell Value |
$3,283,274 |
$3,656,402 |
$4,155,712 |
$4,658,824 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
19 |
23 |
31 |
39 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Frank Morgan C. |
10% Owner |
– – • |
2016-04-21 |
4 |
B |
$2.02 |
$22,220 |
I/I |
11,000 |
2,081,257 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-04-19 |
4 |
B |
$1.92 |
$38,400 |
D/D |
20,000 |
1,544,374 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-04-19 |
4 |
B |
$1.92 |
$38,400 |
I/I |
20,000 |
2,070,257 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-02-11 |
4 |
B |
$1.67 |
$16,867 |
D/D |
10,100 |
1,524,374 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-02-11 |
4 |
B |
$1.67 |
$16,867 |
I/I |
10,100 |
2,050,257 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-02-10 |
4 |
B |
$1.63 |
$17,930 |
D/D |
11,000 |
1,514,274 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-02-10 |
4 |
B |
$1.63 |
$17,930 |
I/I |
11,000 |
2,040,157 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-02-09 |
4 |
B |
$1.67 |
$5,010 |
D/D |
3,000 |
1,503,274 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-02-09 |
4 |
B |
$1.67 |
$5,010 |
I/I |
3,000 |
2,029,157 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-01-28 |
4 |
B |
$2.10 |
$8,400 |
D/D |
4,000 |
1,500,274 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-01-28 |
4 |
B |
$2.10 |
$8,400 |
I/I |
4,000 |
2,026,157 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-01-27 |
4 |
B |
$1.98 |
$9,504 |
D/D |
4,800 |
1,496,274 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2016-01-27 |
4 |
B |
$1.98 |
$9,504 |
I/I |
4,800 |
2,022,157 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-31 |
4 |
B |
$1.77 |
$23,842 |
D/D |
13,300 |
1,491,474 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-31 |
4 |
B |
$1.77 |
$23,842 |
I/I |
13,300 |
2,017,357 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-30 |
4 |
B |
$1.75 |
$1,750 |
D/D |
1,000 |
1,478,174 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-30 |
4 |
B |
$1.75 |
$1,750 |
I/I |
1,000 |
2,004,057 |
1.42 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-29 |
4 |
B |
$1.76 |
$10,560 |
D/D |
6,000 |
1,477,174 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-29 |
4 |
B |
$1.76 |
$10,560 |
I/I |
6,000 |
2,003,057 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-29 |
4 |
B |
$1.76 |
$16,016 |
D/D |
9,100 |
1,471,174 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-29 |
4 |
B |
$1.76 |
$16,016 |
I/I |
9,100 |
1,997,057 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-28 |
4 |
B |
$1.76 |
$19,635 |
D/D |
11,100 |
1,462,074 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-28 |
4 |
B |
$1.76 |
$19,635 |
I/I |
11,100 |
1,987,957 |
1.5 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-23 |
4 |
B |
$1.66 |
$332 |
D/D |
200 |
1,450,974 |
2.37 |
- |
|
| Frank Morgan C. |
10% Owner |
– – • |
2015-12-23 |
4 |
B |
$1.66 |
$332 |
I/I |
200 |
1,976,857 |
1.42 |
- |
|
293 Records found
|
|
Page 8 of 12 |
|
|
0.15 (2.24%) 
